ClinConnect ClinConnect Logo
Search / Trial NCT05901688

Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes

Launched by MEDWAY NHS FOUNDATION TRUST · Jun 5, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking into how problems with the umbilical cord during pregnancy might predict certain complications for the baby. Researchers will measure various aspects of the umbilical cord, such as its thickness and how well blood flows through it, at two points during pregnancy: between 20-22 weeks and again at 35-37 weeks. They want to see if these measurements can help identify pregnancies that might lead to issues like low birth weight, brain injury, stillbirth, or the need for special care in the neonatal unit.

To participate in this study, women must be pregnant with one baby and booked for care at the hospital before reaching 20 weeks of pregnancy. Unfortunately, those with multiple pregnancies, under the age of 16, unable to give consent, or those with known fetal abnormalities cannot join. If eligible, participants can expect to undergo routine ultrasound scans to gather important information about the umbilical cord, which will help improve understanding and care for pregnancies at risk of complications.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Singleton pregnancies.
  • 2. Women booked at our unit prior to 20 weeks' gestation.
  • Exclusion Criteria:
  • 1. Multiple pregnancies.
  • 2. Age \< 16 years.
  • 3. Those unable to provide consent.
  • 4. Pregnancies with fetal abnormalities.

About Medway Nhs Foundation Trust

Medway NHS Foundation Trust is a leading healthcare provider in the United Kingdom, dedicated to delivering high-quality patient care and advancing medical research through clinical trials. With a strong emphasis on innovation and collaboration, the Trust actively participates in various studies aimed at improving treatment outcomes and enhancing patient experiences. Its multidisciplinary team of healthcare professionals is committed to adhering to rigorous ethical standards and regulatory requirements, ensuring that all clinical trials are conducted with the utmost integrity and patient safety in mind. Through its research initiatives, Medway NHS Foundation Trust strives to contribute to the advancement of medical science and the development of new therapeutic options.

Locations

Gillingham, Kent, United Kingdom

Patients applied

0 patients applied

Trial Officials

Ranjit Akolekar, MD MRCOG PhD

Principal Investigator

Medway NHS Foundation Trust

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported